Psyence Biomedical Ltd Common Shares
Quarterly Financials
| Values in thousands | 2024-09-30 | 2023-09-30 |
|---|---|---|
Revenue | $0 | $0 |
EBITDA | -557 | |
EBIT | -1,157 | -557 |
Net Income | 141 | -647 |
Net Change In Cash | 0 | 0 |
Free Cash Flow | -251 | |
Cash | 1,932 | 88 |
Basic Shares | 76 | 7,694 |
Annual Financials
| Values in thousands | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | ||||
EBITDA | -2,751 | -1,293 | -334 | |
EBIT | -3,663 | -2,751 | -1,293 | -334 |
Net Income | 1,011 | -51,159 | 8,014 | 8,230 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -3,744 | -2,951 | -519 | -839 |
Cash | 6,135 | 762 | 128 | 648 |
Basic Shares | 568 | 6,517 | 32,674 | 32,674 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-03-31 | -$99.97 |
2024-12-31 | $4.06 |
2024-09-30 | $4.07 |
2023-09-30 | -$50.32 |
